ARTICLE | Clinical News
Totect regulatory update
January 27, 2014 8:00 AM UTC
Kissei said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for Savene dexrazoxane to treat anthracycline extravasation. The topoisomerase II (TOP2) inhibitor is marketed in the ...